Taipei Exchange - Delayed Quote TWD
TAHO Pharma (6467.TWO)
64.40
+6.70
+(11.61%)
At close: April 25 at 2:53:25 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
Operating Cash Flow
-156,913
-156,913
-104,215
Investing Cash Flow
-188,863
-188,863
-49,044
Financing Cash Flow
439,937
439,937
230,671
End Cash Position
245,868
245,868
151,707
Capital Expenditure
-8,817
-8,817
-2,886
Issuance of Capital Stock
476,906
476,906
234,980
Free Cash Flow
-165,730
-165,730
-107,101
12/31/2023 - 12/30/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6620.TWO Handa Pharmaceuticals, Inc.
73.70
-2.12%
6483.TWO Original BioMedicals Co., Ltd.
12.50
+0.40%
4172.TWO InnoPharmax Inc.
15.70
+2.61%
6539.TWO DV Biomed Co., Ltd.
72.00
+0.70%
6932.TWO Mercury Biopharmaceutical Corporation
13.80
+7.39%
6621.TWO UniPharma Co., Ltd.
15.35
-3.15%
4132.TWO Golden Biotechnology Corporation
14.95
-0.33%
7561.TWO Bioray Biotech Co., Ltd
20.10
+0.25%
4166.TWO Orient Pharma Co., Ltd.
30.60
+0.82%
1780.TWO Allied Biotech Corporation
16.90
-1.74%